摘要:
Alpha7 nicotinic acetylcholine receptors (nAChRs) have implications in the regulation of cognitive processes such as memory and attention and have been identified as a promising therapeutic target for the treatment of the cognitive deficits associated with schizophrenia and Alzheimer's disease (AD). Structure affinity relationship studies of the previously described alpha 7 agonist SEN12333 (8), have resulted in the identification of compound 45, a potent and selective agonist of the alpha 7 nAChR with enhanced affinity and improved physicochemical properties over the parent compound (SEN12333, 8). (C) 2015 Elsevier Masson SAS. All rights reserved.